The MFDS plays a vital role in medical device approval in South Korea by evaluating safety, efficacy, and quality through a rigorous review process. It classifies devices based on risk, requires comprehensive documentation for pre-market submissions, conducts facility inspections, and monitors post-market... Read More
The MFDS enforces drug advertising regulations by reviewing promotional materials for compliance with established guidelines. It monitors advertising practices, investigates complaints, and conducts inspections. The agency ensures that advertisements provide accurate information, avoid misleading claims, and adhere to ethical standards, taking action... Read More
The MFDS requirements for clinical trials in drug registration include obtaining ethical approval, ensuring compliance with Good Clinical Practice (GCP) standards, and submitting detailed trial protocols. Sponsors must provide comprehensive data on study design, participant recruitment, safety monitoring, and data analysis methods.... Read More
The MFDS handles drug labeling regulations by establishing comprehensive guidelines that ensure accurate and clear information on product labels. Labels must include essential details such as active ingredients, dosage, indications, contraindications, and side effects. The MFDS reviews and approves labeling to prevent... Read More
The MFDS handles several types of drug applications, including New Drug Applications (NDA) for new chemical entities, Biologics License Applications (BLA) for biologics, Abbreviated New Drug Applications (ANDA) for generics, and Investigational New Drug (IND) applications for clinical trials. Each undergoes a... Read More
The MFDS ensures compliance with Good Manufacturing Practice (GMP) through regular inspections, audits, and certification processes. It evaluates manufacturing facilities for adherence to GMP standards, covering quality control, hygiene, and safety. Non-compliance may result in corrective actions, penalties, or license suspension to... Read More
The MFDS review process for new active ingredients involves several stages: submission of a comprehensive dossier, preclinical and clinical data evaluation, safety and efficacy assessment, and quality control checks. The process includes a scientific review, expert consultations, and potential on-site inspections before... Read More
The MFDS manages biologics registration through a rigorous process that includes preclinical and clinical trial evaluations, safety and efficacy assessments, and manufacturing inspections. Applicants must submit detailed data on the biologic’s quality, safety, and effectiveness. Post-market surveillance ensures continued compliance with safety... Read More
The MFDS (Ministry of Food and Drug Safety) is the current regulatory body in South Korea responsible for overseeing drug safety and approval. The KFDA (Korea Food and Drug Administration) was its predecessor. The MFDS replaced the KFDA in 2013, assuming its... Read More
The MFDS ensures that generics meet bioequivalence requirements by mandating comparative studies between the generic and the reference drug. These studies must demonstrate that the generic has similar pharmacokinetics, including absorption, distribution, metabolism, and excretion. The results are rigorously evaluated to confirm... Read More